Efficacy of interferon alpha 2a in 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: A randomized phase III DeCOG trial

Hauschild, A. and Volkenandt, M. and Tilgen, W. and Linse, R. and Boettjer, J. and Vogt, T. and Spieth, K. and Eigentler, T. and Brockmeyer, N. H. and Weichenthal, M. (2008) Efficacy of interferon alpha 2a in 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: A randomized phase III DeCOG trial. JOURNAL OF CLINICAL ONCOLOGY, 26 (15supp): 9032. ISSN 0732-183X

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 14 Jan 2021 16:05
Last Modified: 14 Jan 2021 16:05
URI: https://pred.uni-regensburg.de/id/eprint/30891

Actions (login required)

View Item View Item